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Abstract
Introduction: Light before and during acute illness has been associated with both benefit and harm in animal
models and small human studies. Our objective was to determine the associations of light duration (photoperiod)
and intensity (insolation) before and during critical illness with hospital mortality in ICU patients. Based on the
‘winter immunoenhancement’ theory, we tested the hypothesis that a shorter photoperiod before critical illness is
associated with improved survival.
Methods: We analyzed data from 11,439 patients admitted to 8 ICUs at the University of Pittsburgh Medical Center
between June 30, 1999 and July 31, 2004. Daily photoperiod and insolation prior to and after ICU admission were
estimated for each patient by using data provided by the United States Naval Observatory and National
Aeronautics and Space Administration and direct measurement of light gradient from outside to bedside for each
ICU room. Our primary outcome was hospital mortality. The association between light and risk of death was
analyzed using multivariate analyses, adjusting for potential confounders, including severity of illness, case mix, and
ICU type.
Results: The cohort had an average APACHE III of 52.9 and a hospital mortality of 10.7%. In total, 128 ICU beds
were analyzed; 108 (84%) had windows. Pre-illness photoperiod ranged from 259 to 421 hours in the prior month.
A shorter photoperiod was associated with a reduced risk of death: for each 1-hour decrease, the adjusted OR was
0.997 (0.994 to 0.999, p = 0.03). In the ICU, there was near complete (99.6%) degradation of natural light from
outside to the ICU bed. Thus, light exposure once in the ICU approached zero; the 24-hour insolation was 0.005 ±
0.003 kWh/m2 with little diurnal variation. There was no association between ICU photoperiod or insolation and
mortality.
Conclusions: Consistent with the winter immunoenhancement theory, a shorter photoperiod in the month before
critical illness is associated with a reduced risk of death. Once in the ICU, patients are exposed to near negligible
natural light despite the presence of windows. Further studies are warranted to determine the underlying
mechanisms and whether manipulating light exposure, before or during ICU admission, can enhance survival.
Introduction
Sunlight has profound effects on life. Although we are all
generally aware of the sense of well-being induced by
more sunlight, both more and less light trigger important
adaptive changes in our underlying physiology. Seasonal
physiologic adaptations in biological stress responses
have been observed consistently in many animal species
[1-4]. Superimposed are diurnal changes that are influ-
enced by the duration of daily light exposure or photo-
period [5]. The consequences of these adaptive changes
on critical illness are unclear. On the one hand, some
studies have reported reduced mortality in patients with
myocardial infarction and less delirium and post-opera-
tive pain in critically ill surgical patients after exposure to
bright natural light or windows [6-8]. On the other hand,
a shorter duration of light exposure prior to stress may
promote survival. A non-visual optic pathway, respond-
ing to a shorter photoperiod, heightens the synthesis and
release of melatonin and thereby enhances immunity
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[2,9,10]. Animals exposed to this short photoperiod exhi-
bit marked resistance to endotoxemia, characterized by
attenuated inflammation, earlier termination of the sick
response, and improved survival: this is known as the
winter immunoenhancement theory [11].
One limitation of prior clinical studies has been the
absence of data quantifying and qualifying the exposure
to light. Light is complex and is defined by photoperiod
(that is, duration), insolation (that is, intensity), and
wavelength. Few studies have incorporated this complex-
ity into a study design. Contemporary medical monitors,
continuous in use and ubiquitous throughout the inten-
sive care unit (ICU), are rich in blue spectrum, which
functions biologically as daylight [12-16]. Thus, the null
results of more recent studies may stem from the near-
constant, low-intensity, high-in-blue-spectrum lighting
prevalent in ICUs. In this study, we wished to character-
ize the insolation and photoperiod of light exposure both
prior to and during critical illness and determine the
association of each with patient outcome. Our primary
objective was to explore whether the duration or inten-
sity of light, either prior to or during illness, is associated
with outcome. In accordance with prior biological stu-
dies, we hypothesized that a shorter photoperiod is asso-
ciated with improved survival.
Materials and methods
Study design
We conducted an observational retrospective cohort
study, using the University of Pittsburgh Medical Center
(UPMC) Acute Physiology and Chronic Health Evaluation
(APACHE) III dataset. This dataset ran for many years
and calculated APACHE III scores for every third patient.
We linked data from this dataset to electronic demo-
graphic and clinical data from the HiDenIC (High-Density
Intensive Care) database, which retrospectively collects
information on patients admitted to the ICU at the UPMC
main campus hospitals [17]. This study was approved by
the Institutional Review Board of the University of Pitts-
burgh. Because all data were deidentified, consent was not
required.
Patients
Demographic and physiologic variables were available for
11,439 patients admitted to eight ICUs from 30 June 1999
to 31 July 2004. Of these patients, 9,534 had complete cov-
ariate data and were analyzed. To avoid the counting of
multiple ICU outcomes for a single patient, only the first
admission to an ICU for each patient was considered. The
primary outcome variable was hospital mortality during
the index admission. Many patients undergo elective
scheduled ICU admission (for example, post-operative
observation or extubation). Thus, we focused our analysis
upon patients requiring more than 24 hours of ICU care.
Sunlight exposure
We obtained photoperiod and insolation data from the US
Naval Observatory (USNO) and the National Aeronautics
and Space Administration (NASA). Precise photoperiod
duration in hours and minutes and insolation, a measure
of the solar energy striking a unit surface area in a unit
time (kilowatt hours per square meter per day), were
obtained at the exact longitude and latitude of UPMC
Presbyterian University Hospital and Montefiore Univer-
sity Hospital (+40.447°N -79.9517°W) for each subject for
each calendar day from 60 days prior to the period of hos-
pitalization until the period ended. Variations of light in
the hospital referral region and in the patient’s primary
residence were minimal. Thus, for pre-illness values,
patients were assigned the photoperiod and insolation
values of these coordinates.
For prior light exposure, we used photoperiod. Owing
to a lack of information about a person’s geographic loca-
tion and real outdoor/indoor exposure, cumulative inso-
lation could not be estimated accurately at the subject
level. Both variables exhibited moderate collinearity: var-
iance inflation factor (VIF) of 7, tolerance of 0.14, and
conditional index of 32. Owing to the combined inability
to accurately determine pre-illness insolation and the
substantial collinearity, we restricted our analysis of pre-
illness light exposure to photoperiod.
To determine light exposure once admitted to the ICU,
we multiplied the raw NASA outdoor values for the main
campus hospitals by room-specific light signal degradation
ratios. These were adjusted at the ICU level to account for
the signal degradation that occurs between the outside
and the ICU bed, and the variation in sunlight exposure
due to the geometric position of the ICU window relative
to the sun. Outside and on-site light unit-specific mea-
surements were performed with a digital photometer
(RAC) with the window blinds open and then closed.
Thus, an ICU-specific adjusted insolation value for each
day of ICU hospitalization was calculated. An insolation
value of zero was assigned to ICUs without windows.
Variables and risk adjustment
Cumulative photoperiod prior to ICU hospitalization was
defined as the total hours of daylight for the days preced-
ing hospitalization. Our primary analysis was for cumula-
tive 28-day photoperiod prior to ICU admission as
evidence supports the view that measurable induction of
immunoenhancement (for example, lymphocyte sponta-
neous blastogenesis) is first observed significantly after a
4-week exposure to altered photoperiod duration [18].
Secondary analyses were performed for 7- and 60-day
cumulative photoperiods. Cumulative insolation after
ICU admission was defined as total kilowatt hours per
square meter per day after admission. Our primary analy-
sis was for 24-hour insolation; we performed secondary
Castro et al. Critical Care 2012, 16:R132
http://ccforum.com/content/16/4/R132
Page 2 of 8
analyses for 48- and 72-hour insolation. In each of these
analyses, we excluded patients dying prior to the full per-
iod (for example, 24, 48, or 72 hours) of insolation.
The association between photoperiod and outcome was
examined with photoperiod as a continuous variable, and
the reference category was the highest cumulative 28-day
photoperiod. We also categorized photoperiod into quar-
tiles, and the reference category was the highest photo-
period quartile.
We addressed potential confounding due to variation
in the case mix by controlling for the severity of illness
and additional variables related to the outcome. The
severity of illness was determined according to the
APACHE III score (range of 0 to 299), and higher values
indicated a greater severity of illness and risk of death on
the day of ICU admission. Other risk-adjustment vari-
ables were age, sex, race (African-American, Caucasian,
and other), the season of admission (defined by the equi-
noxes and solstices for each year as detailed by the
USNO), the primary diagnosis at ICU admission (cardio-
vascular, pulmonary, gastrointestinal, trauma, sepsis,
malignancy, renal failure, neuropsychiatric, immunodefi-
ciency, and other), the location of the patient prior to
ICU admission (home versus hospital), and the type of
ICU (medical, surgical, coronary, cardiothoracic, or
transplant).
Statistical analyses
Univariate analyses of continuous and categorical vari-
ables were performed with Student t test and Pearson’s
chi-squared test as appropriate. We performed a random
effects multivariate logistic regression to assess the asso-
ciation between cumulative photoperiod or adjusted ICU
insolation and the risk of mortality, calculated crude and
adjusted odds ratios (ORs) with 95% confidence intervals
(CIs), and accounted for the correlation within ICUs and
covariates specified a priori as potential confounders. For
our primary analysis, the Pearson’s test of goodness of fit
was a P value of greater than 0.05. For each analysis, we
included age, sex, race, season, admission diagnosis, ICU
location, and APACHE III score. We ascertained the
absence of serious collinearity between season and cumu-
lative photoperiod by calculating VIFs and tolerance
values, demonstrating a VIF of less than 5 and tolerance
of greater than 0.2 in all circumstances. A separate analy-
sis without adjustment for severity of illness was per-
formed as acute changes in physiology (that is, APACHE
III score) may or may not occur in the causal mechanism.
We explored whether the association between light and
mortality varied with season, race, or admission diagnosis
by including an interaction term between light and these
covariates. For the assessment of insolation and photo-
period as a continuous variable, we also used the frac-
tional polynomial method, an iterative estimation process
that determines the best-fitting polynomial-regression
function [19]. This method makes no underlying assump-
tions about the relationship between photoperiod or
insolation and outcome and thereby averts the potential
bias involved in pre-specifying the functional form. By
separating the period before ICU admission from the
period during ICU admission, we also accounted for
potential immortal time bias, a situation that refers to
cohort follow-up time in a time-to-event analysis like our
study; owing to the exposure definition, the outcome
under study could not occur during the follow-up time
[20]. Statistical analyses were performed with Stata 11.2
(StataCorp LP, College Station, TX, USA). A P value of
less than 0.05 was considered significant.
Results
In total, 11,439 index ICU admissions during the period
of study were available for analysis. The final adjusted
analysis included 9,534 patients admitted to eight ICUs
at two hospitals. The cohort had an average APACHE III
score of 52.9 and a hospital mortality of 10.7%. The char-
acteristics of patients and seasons are shown in Table 1.
Pre-admission
Seasonal variation in regional photoperiod and insolation
are displayed in Figure 1a-d. The magnitude of and varia-
tion in cumulative pre-admission photoperiod were lowest
during winter (Figure 1b and Table 2). After adjustment
for severity of illness, age, sex, race, the season, diagnosis
at admission, and ICU location, a 1-hour decrease in
cumulative 28-day photoperiod was associated with a sig-
nificant decrease in hospital mortality (adjusted OR 0.997,
95% CI 0.994 to 0.999; P = 0.03) (Table 3). Thus, in com-
parison with patients in the highest quartile of cumulative
28-day photoperiod, patients in the lowest quartile had a
decreased risk of death (adjusted OR 0.69, 95% CI 0.47 to
1.01; P = 0.06). Figure 2 shows the effect of cumulative
28-day photoperiod when examined as a continuous vari-
able in a multivariate model. Decreased mortality is seen
throughout the distribution as photoperiod decreases from
the highest to the lowest value. This relationship did not
vary significantly by season, race, or admission diagnosis
(interaction term between each covariate and photoperiod,
P >0.10). Restricting our analysis to those patients
admitted to the ICU within 24 hours of hospitalization did
not alter these results (adjusted OR 0.996, 95% CI 0.993 to
1.000; P = 0.04). We also analyzed the effect of photoper-
iod without adjusting for APACHE III score since, accord-
ing to the winter immunoenhancement theory, acute
changes in physiology could be part of the causal mechan-
ism (adjusted OR 0.998, 95% CI 0.0.995 to 1.001; P = 0.14)
(Table 3).
We analyzed pre-admission exposure periods both
shorter and longer than the 28-day threshold we
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hypothesized for biological effects. Decreasing cumula-
tive 60-day pre-admission photoperiod continued to be
associated with reduced risk of death (adjusted OR
0.998, 95% CI 0.997 to 0.999; P = 0.01). However, a sig-
nificant association was not observed when examining a
cumulative 7-day photoperiod (adjusted OR 0.989, 95%
CI 0.977 to 1.001; P = 0.07). There was no association
between season and risk of death (Tables 1 and 4).
However, after adjusting for pre-admission photoperiod,
both fall and winter were associated with an increased
risk of death in comparison with spring (Table 4).
Intensive care unit
We observed an enormous degradation (>99.6%) of nat-
ural radiant light from outdoors to the ICU bed (Figure
1c). Thus, the exposure to natural light, once in the
ICU, approached zero; the 24-hour insolation was 0.005
± 0.003 kWh/m2 and there was little diurnal variation
(Figure 1d and Table 5). There was no association
between ICU photoperiod or insolation and hospital
mortality (data not shown).
Discussion
Our results bring attention to the complexity of light and
emphasize the importance of quantifying and qualifying
its dimensions in the context of clinical studies. We
observed that, prior to admission, a shorter photoperiod
is associated with a reduced risk of death among critically
ill patients. This association persists after controlling for
relevant confounders, a sensitivity analysis in which a
variety of modeling assumptions were tested, and ana-
lyses that separately assessed light duration and intensity.
However, once in the ICU, light exposure is negligible
and lacking in diurnal variation. These observations sug-
gest that light is relevant to human biology in the context
of critical illness. Yet further study is needed to deter-
mine the potential utility of light manipulation as a
meaningful intervention in health and disease.
Prior studies of myocardial infarction and critically ill
surgical patients noted reduced mortality, delirium, and
post-operative pain in patients exposed to bright natural
light or windows while hospitalized [6-8]. The same
effect has been observed in patients hospitalized for
Table 1 Characteristics of patients according to season
Characteristic Season P value
Spring
(n = 2,566)
Summer
(n = 2,367)
Fall
(n = 2,275)
Winter
(n = 2,326)
Age, yearsa 60.1 ± 17.8 59.6 ± 18.0 60.4 ± 18.0 60.1 ± 17.6 0.48
Sex, percentage
Male 58.9 58.6 59.7 58.7 0.89
Race, percentage
Caucasian 79.1 81.5 81.0 79.1 0.04
African-American 14.0 11.3 11.9 14.2
Other 6.9 7.2 7.1 6.7
APACHE III scorea 51.4 ± 25.2 51.5 ± 25.4 52.9 ± 26.0 52.6 ± 26.4 0.09
Diagnostic category, percentage
Cardiovascular 28.1 28.2 31.9 28.8 0.01
Trauma 15.4 17.3 14.7 13.9 0.01
Gastrointestinal 9.5 8.3 9.5 9.2 0.41
Sepsis 6.5 5.4 7.1 6.8 0.09
Solid tumors 5.9 4.9 4.2 5.0 0.06
Neuropsychiatric 4.8 3.6 4.0 4.5 0.18
Pulmonary 4.1 3.7 4.6 4.2 0.50
Renal 1.0 1.1 0.9 1.1 0.87
Immunodeficiency 0.3 0.6 0.2 0.4 0.12
Other 24.6 26.8 23.0 26.1 0.01
Type of ICU, percentage
Medical 32.9 33.1 29.8 32.9 0.05
Coronary care 10.7 9.6 11.7 9.9 0.07
Cardiothoracic 30.0 32.2 34.2 31.3 0.02
Surgical 6.2 6.3 7.2 5.4 0.07
Multidisciplinary 20.2 18.8 17.1 20.5 0.02
Length of stay, daysa 4.8 ± 6.6 5.2 ± 9.2 4.9 ± 6.6 5.1 ± 6.9 0.97
Mortality, percentage 10.2 10.0 11.4 11.2 0.29
aValues are expressed as mean ± standard deviation. APACHE III, Acute Physiology and Chronic Health Evaluation III; ICU, intensive care unit.
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depression [7]. Newer studies have failed to replicate
these findings [21]. We observed a near-complete loss of
natural light exposure in the ICU. Thus, we were unable
to meaningfully assess the association between insolation
and outcome. These data and those of other studies also
demonstrate the limited diurnal variation of light in the
ICU [22]. Blue light, a predominant wavelength of mod-
ern light-emitting diode monitors, functions as daylight
and most powerfully suppresses melatonin and cortisol
secretion [12-14]. Coupled to the altered patterns of illu-
mination inherent in ‘24-hour around-the-clock’ ICU
care, these mechanisms of perturbed light exposure
may underlie the null results of other studies of the
association between light, windows, and the outcome of
ICU patients [21].
The underlying mechanism by which the photoperiod
prior to admission would alter the outcome of critical ill-
ness is unknown. It is well known that the immune
response to antigen differs quantitatively and qualitatively
depending upon the duration of exposure to light [9,23].
In animal models, manipulating the day length modifies
immunity toward either enhancement (shorter photoper-
iod) or relative depression (longer photoperiod), even
during the winter [3,24-26]. Thus, the observed reduction
in mortality with shorter photoperiods may be the conse-
quence of adaptive alterations in immunity.
Figure 1 Characteristics of insolation and photoperiod. (a) Daily insolation and photoperiod from 30 June 1999 to 31 July 2004 (+40.447°N
-79.9517°W). (b) Cumulative photoperiod before intensive care unit (ICU) admission, according to season. (c) Degradation of light signal (lux)
from outdoors to ICU bed on sunny and cloudy days. (d) Adjusted cumulative ICU insolation (expressed in kilowatt hours per square meter)
according to season.
Table 2 Cumulative photoperiod prior to intensive care unit admission according to season
Photoperiod Season P value
Spring Summer Fall Winter
At 7 days 96.4 ± 6.8 98.3 ± 5.9 73.8 ± 6.6 72.2 ± 5.9 <0.001
At 28 days 374.8 ± 29.0 400.5 ± 19.4 306.1 ± 28.4 281.1 ± 19.2 <0.001
At 60 days 764.3 ± 65.7 870.9 ± 25.2 694.7 ± 63.9 589.8 ± 24.0 <0.001
Values are expressed as mean ± standard error of the mean. Photoperiod is expressed in hours.
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The winter immunoenhancement theory proposes that,
during seasonal changes in environmental stress (that is,
winter), selection favors individuals exhibiting enhanced
immune function as a result of seasonal energetic redis-
tribution and adjustments in reproduction, growth, and
other responses [1,2,27]. It is important to appreciate
that immunoenhancement is not synonymous with pro-
inflammation. To the contrary, anti-inflammatory and
regulatory immune functions are also enhanced. Thus,
animals use photoperiodic information to anticipate and
prepare for the energetically challenging conditions of
winter. Similar mechanisms may be induced during the
‘physiologic winter’ of life-threatening illness and the
accompanying massive energetic expenditures of abnor-
mal protein metabolism, fatty acid degradation, and
circulating inflammatory mediators [28]. Indeed, our
results suggest that the human response to critical illness
is conditioned by the predominant photoperiod as we
observed reduced mortality with shorter photoperiods
and longer nights. Determining the underlying mechan-
isms will require prospective longitudinal studies of the
association between these characteristics of light and
parameters of the inflammatory and neuroendocrine
response to illness.
Season is strongly associated with the epidemiology of
disease. Apart from photoperiod and immune responses,
variations in day length and season are associated with
relevant changes in ambient temperatures, humidity, biotic
growth, food quality and quantity, water availability, and
animal and human behavior, as well [4,29,30]. To capture
these intangible factors in our model, we incorporated the
composite variable of seasons. Winter and fall proved to
be the seasons with highest mortality. We speculate that
mortality may have been even higher in the absence of
immunoenhancement. Indeed, after adjustment for the
adaptive effect of cumulative photoperiod (for example,
cumulative 28-day pre-admission photoperiod), the
adjusted risk of death in winter was much greater than
that in spring and summer.
Our study is limited by the accuracy of patient records
and the reduced size of the cohort available for analysis
due to random calculation of the severity score. We were
unable to characterize individual-specific variations in
sleeping patterns, regions of residence, and patterns of
activity (indoors versus outdoors). Thus, we assumed
that patients possessing the same day of ICU admission
were exposed to the same cumulative photoperiod and
insolation prior to ICU admission. These characteristics
would have little effect on photoperiod duration (that is,
the length of day), our primary exposure of interest and
the one associated with mortality. We do not have biolo-
gical patient data. Hence, the observed associations may
Table 3 Association between cumulative 28-day
photoperiod and outcome
Exposure Odds ratioa 95% CI P value
Photoperiod28d
ALLb 0.997 0.994-0.999 0.03
ALL (-APACHE III)c 0.998 0.995-1.001 0.14
Photoperiod28d quartiles
b
First quartile 0.69 0.47-1.01 0.06
Second quartile 0.79 0.57-1.10 0.16
Third quartile 0.88 0.70-1.11 0.11
Fourth quartile Referent
aFor each 1-hour increase in cumulative 28-day photoperiod. bAdjusted for
Acute Physiology and Chronic Health Evaluation (APACHE) III, age, sex, race,
season, admission diagnosis, and intensive care unit (ICU) location. cAdjusted
for age, sex, race, season, admission diagnosis, and ICU location. CI,
confidence interval.
Figure 2 Association between cumulative 28-day photoperiod
and mortality. The association between cumulative 28-day pre-
admission photoperiod and in-hospital mortality was examined by
using multivariate logistic regression and the fractional polynomial
method. The adjusted odds ratio of death with decreasing
cumulative 28-day pre-admission photoperiod is depicted. The
reference category is the highest cumulative 28-day pre-admission
photoperiod.
Table 4 Association between season and outcome
Exposure Odds ratioa 95% CI P value
Seasonsa
Spring Referent
Summer 1.01 0.82-1.25 0.90
Fall 1.08 0.88-1.33 0.46
Winter 1.08 0.87-1.33 0.49
Seasonsb
Spring Referent
Summer 0.93 0.74-1.16 0.52
Fall 1.35 1.01-1.81 0.04
Winter 1.46 1.03-2.08 0.03
aAdjusted for Acute Physiology and Chronic Health Evaluation (APACHE) III,
age, sex, race, admission diagnosis, and intensive care unit (ICU) location.
bAdjusted for APACHE III, age, sex, race, admission diagnosis, ICU location, and
cumulative 28-day photoperiod. CI, confidence interval.
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be due to altered provider care rather than an effect on a
specific biological process within the patient.
Conclusions
Lower exposure to sunlight prior to critical illness
appears to be associated with improved outcome. These
adaptive changes are sensitive to induction throughout
the whole year. Although an individual may abruptly
become critically ill at any time of the year, many other
events such as cardiopulmonary bypass and major opera-
tion can be anticipated. In such circumstances, a window
of opportunity to influence patient outcome might exist.
Once in the ICU, the predominant lighting exposure is of
low intensity and limited diurnal variation. Future studies
of light exposure after hospitalization will require artifi-
cial means of manipulating light insolation and wave-
length to achieve levels possessing biological effects.
The precise timing and characteristics of such an inter-
vention remain to be elucidated. Nonetheless, validating
these associations and understanding the underlying
mechanisms may guide immune-modulating therapy or
even the development of new therapeutic interventions.
Key messages
Lower exposure to sunlight prior to critical illness
appears to be associated with improved outcome.
Once in the ICU, the predominant lighting exposure is
of low intensity and limited diurnal variation.
Manipulating light exposure prior to admission and
during the initial period after admission may enhance
survival for patients who are expected to receive a major
biological insult.
The precise timing and characteristics of such an
intervention remain to be elucidated.
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